These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3583398)

  • 1. Reactions of nitrogen mustards with DNA.
    Hemminki K; Kallama S
    IARC Sci Publ; 1986; (78):55-70. PubMed ID: 3583398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
    Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
    Turner PR; Denny WA; Ferguson LR
    Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.
    Maccubbin AE; Caballes L; Chheda GB; Struck RF; Gurtoo HL
    Biochem Biophys Res Commun; 1989 Sep; 163(2):843-50. PubMed ID: 2783126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR; Souhami RL; McLean AE
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
    Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
    Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the d(CGCGAATTCGCG)2 complex of the minor groove binding alkylating agent alkamin studied by mass spectrometry.
    Majid AM; Smythe G; Denny WA; Wakelin LP
    Mol Pharmacol; 2007 Apr; 71(4):1165-78. PubMed ID: 17251328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K
    Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorambucil-adducts in DNA analyzed at the oligonucleotide level using HPLC-ESI MS.
    Mohamed D; Mowaka S; Thomale J; Linscheid MW
    Chem Res Toxicol; 2009 Aug; 22(8):1435-46. PubMed ID: 19621941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard.
    Fleer R; Brendel M
    Chem Biol Interact; 1982 Mar; 39(1):1-15. PubMed ID: 7037214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF
    Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.
    Brock N
    Cancer Treat Rep; 1976 Apr; 60(4):301-8. PubMed ID: 1277205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
    Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
    Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage and mutagenesis induced by nitrogen mustards.
    Povirk LF; Shuker DE
    Mutat Res; 1994 Dec; 318(3):205-26. PubMed ID: 7527485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
    McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
    Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
    Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
    Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous cross-linking by mechlorethamine of DNA duplexes containing C-C mismatch pairs.
    Romero RM; Mitas M; Haworth IS
    Biochemistry; 1999 Mar; 38(12):3641-8. PubMed ID: 10090751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5815-20. PubMed ID: 6640533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM; Wodinsky I; Myles A
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.